Found: 5
Select item for more details and to access through your institution.
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy.
- Published in:
- Journal of Ovarian Research, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13048-023-01313-z
- By:
- Publication type:
- Article
Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5694, doi. 10.3390/cancers15235694
- By:
- Publication type:
- Article
NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumorassociated antigens.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1295208
- By:
- Publication type:
- Article
Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 1, p. 73, doi. 10.3390/cells13010073
- By:
- Publication type:
- Article
Mesenchymal ovarian cancer cells promote CD8<sup>+</sup> T cell exhaustion through the LGALS3-LAG3 axis.
- Published in:
- NPJ Systems Biology & Applications, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41540-023-00322-4
- By:
- Publication type:
- Article